| Reference |
|---|
Shimoda Y, Murakoshi N, Mori H, Xu D, Tajiri K, Hemmi Y, et al. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation. Stem Cell Res. 2022;62:102793 pubmed publisher |
Miyata S, Saku N, Akiyama S, Javaregowda P, Ite K, Takashima N, et al. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI). Stem Cell Res Ther. 2022;13:6 pubmed publisher |
Luo Y, Chen Y, Zhang M, Ma X, Zhu D, Chen Y. Generation of an induced pluripotent stem cell line GZHMCi008-A derived from a patient with SRY-positive 46,XX testicular disorder of sex development. Stem Cell Res. 2021;57:102583 pubmed publisher |
Mehta A, LU P, Taylor B, Charlesworth J, Cook A, Burdon K, et al. Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis. Stem Cell Res. 2021;57:102568 pubmed publisher |
Cañibano Hernández A, Valdés Sánchez L, García Delgado A, Ponte Zuñiga B, Diaz Corrales F, De la Cerda B. Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene. Stem Cell Res. 2021;53:102301 pubmed publisher |
Haase A, Kohrn T, Fricke V, Ricci Signorini M, Witte M, Göhring G, et al. Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives. Stem Cell Res. 2021;52:102206 pubmed publisher |
Geuder J, Wange L, Janjić A, Radmer J, Janssen P, Bagnoli J, et al. A non-invasive method to generate induced pluripotent stem cells from primate urine. Sci Rep. 2021;11:3516 pubmed publisher |
Merkert S, Jaboreck M, Engels L, Malik M, Göhring G, Pessler F, et al. Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing. Stem Cell Res. 2020;50:102135 pubmed publisher |
Jin L, Chen Y, Crossman D, Datta A, Vu T, Mobley J, et al. STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells. Nat Commun. 2020;11:5941 pubmed publisher |
Li Y, Liu H, Jin Z. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation. Stem Cell Res. 2020;49:102075 pubmed publisher |
Jamil M, Singer H, Al Rifai R, Nüsgen N, Rath M, Strauss S, et al. Molecular Analysis of Fetal and Adult Primary Human Liver Sinusoidal Endothelial Cells: A Comparison to Other Endothelial Cells. Int J Mol Sci. 2020;21: pubmed publisher |
Kamand M, Ilieva M, Louise Forsberg S, Thomassen M, Meyer M, Fex Svenningsen A, et al. Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem Cell Res. 2020;48:101974 pubmed publisher |
Ovechkina V, Maretina M, Egorova A, Baranov V, Kiselev A, Zakian S, et al. Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A. Stem Cell Res. 2020;48:101938 pubmed publisher |
Takahashi K, Jeong D, Wang S, Narita M, Jin X, Iwasaki M, et al. Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells. Cell Rep. 2020;31:107715 pubmed publisher |
Kamand M, Ilieva M, Forsberg S, Thomassen M, Fex Svenningsen A, Holst B, et al. Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem Cell Res. 2020;46:101834 pubmed publisher |
Pongpamorn P, Dahlmann J, Haase A, Ebeling C, Merkert S, Göhring G, et al. Generation of three induced pluripotent stem cell lines (MHHi012-A, MHHi013-A, MHHi014-A) from a family with Loeys-Dietz syndrome carrying a heterozygous p.M253I (c.759G>A) mutation in the TGFBR1 gene. Stem Cell Res. 2020;43:101707 pubmed publisher |
Fuchs N, Schieck M, Neuenkirch M, Tondera C, Schmitz H, Wendeburg L, et al. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1). Stem Cell Res. 2020;43:101697 pubmed publisher |
Haake K, Wüstefeld T, Merkert S, Lüttge D, Göhring G, Auber B, et al. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis. Stem Cell Res. 2020;43:101713 pubmed publisher |
Fuchs N, Schieck M, Neuenkirch M, Tondera C, Schmitz H, Steinemann D, et al. Induced pluripotent stem cell line (PEIi003-A) derived from an apparently healthy male individual. Stem Cell Res. 2020;42:101679 pubmed publisher |
Rodríguez Traver E, Diaz Guerra E, Rodriguez C, Arenas F, Orera M, Kulisevsky J, et al. A collection of three integration-free iPSCs derived from old male and female healthy subjects. Stem Cell Res. 2020;42:101663 pubmed publisher |
Hiramoto T, Tahara M, Liao J, Soda Y, Miura Y, Kurita R, et al. Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells. Mol Ther. 2020;28:129-141 pubmed publisher |
Diaz Guerra E, Rodríguez Traver E, Moreno Jiménez E, de Rojas I, Rodriguez C, Orera M, et al. An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-ε4/ε4 alleles. Stem Cell Res. 2019;41:101588 pubmed publisher |
Fuchs N, Schieck M, Neuenkirch M, Tondera C, Schmitz H, des Portes V, et al. Induced pluripotent stem cells (iPSCs) derived from a renpenning syndrome patient with c.459_462delAGAG mutation in PQBP1 (PEIi001-A). Stem Cell Res. 2019;41:101592 pubmed publisher |
Diaz Guerra E, Oria Muriel M, Moreno Jiménez E, de Rojasb I, Rodriguez C, Rodríguez Traver E, et al. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation. Stem Cell Res. 2019;40:101574 pubmed publisher |
Rodríguez Traver E, Rodriguez C, Diaz Guerra E, Arenas F, Araúzo Bravo M, Orera M, et al. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene. Stem Cell Res. 2019;40:101578 pubmed publisher |
Ma X, Wang S, Liu S, Chen K, Wu Z, Li D, et al. Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World J Gastroenterol. 2019;25:3030-3043 pubmed publisher |
Rodríguez Traver E, Diaz Guerra E, Rodriguez C, Fernandez P, Arenas F, Araúzo Bravo M, et al. A collection of integration-free iPSCs derived from Parkinson's disease patients carrying mutations in the GBA1 gene. Stem Cell Res. 2019;38:101482 pubmed publisher |
De la Cerda B, Díez Lloret A, Ponte B, Vallés Saiz L, Calado S, Rodríguez Bocanegra E, et al. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene. Stem Cell Res. 2019;36:101426 pubmed publisher |
Castelli A, Susani L, Menale C, Muggeo S, Caldana E, Strina D, et al. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells. Stem Cells. 2019;37:876-887 pubmed publisher |
Gao X, Yourick J, Sprando R. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel. Stem Cell Res. 2018;31:193-196 pubmed publisher |
Higelin J, Catanese A, Semelink Sedlacek L, Oeztuerk S, Lutz A, Bausinger J, et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 2018;30:150-162 pubmed publisher |
Bolinches Amorós A, Lukovic D, Castro A, León M, Kamenarova K, Kaneva R, et al. Generation of a human iPSC line from a patient with congenital glaucoma caused by mutation in CYP1B1 gene. Stem Cell Res. 2018;28:96-99 pubmed publisher |
Tanaka Y, Sone T, Higurashi N, Sakuma T, Suzuki S, Ishikawa M, et al. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem Cell Res. 2018;28:100-104 pubmed publisher |
Zhang J, Cao H, Xie J, Fan C, Xie Y, He X, et al. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation. Cell Death Dis. 2018;9:224 pubmed publisher |
Cao S, Yu S, Chen Y, Wang X, Zhou C, Liu Y, et al. Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage. J Biol Chem. 2017;292:19122-19132 pubmed publisher |
Merkert S, Bednarski C, Göhring G, Cathomen T, Martin U. Generation of a gene-corrected isogenic control iPSC line from cystic fibrosis patient-specific iPSCs homozygous for p.Phe508del mutation mediated by TALENs and ssODN. Stem Cell Res. 2017;23:95-97 pubmed publisher |
Schmidt A, Woedtke T, Stenzel J, Lindner T, Polei S, Vollmar B, et al. One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet. Int J Mol Sci. 2017;18: pubmed publisher |
Bolnick J, Kohan Ghadr H, Fritz R, Bolnick A, Kilburn B, Diamond M, et al. Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease. Sci Rep. 2016;6:32382 pubmed publisher |
Kawaguchi T, Tsukiyama T, Kimura K, Matsuyama S, Minami N, Yamada M, et al. Generation of Naïve Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors. PLoS ONE. 2015;10:e0135403 pubmed publisher |
Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE. 2015;10:e0129855 pubmed publisher |
Nguyen L, Robinton D, Seligson M, Wu L, Li L, Rakheja D, et al. Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell. 2014;26:248-61 pubmed publisher |
Ohnuma K, Fujiki A, Yanagihara K, Tachikawa S, Hayashi Y, Ito Y, et al. Enzyme-free passage of human pluripotent stem cells by controlling divalent cations. Sci Rep. 2014;4:4646 pubmed publisher |
Yamasaki S, Taguchi Y, Shimamoto A, Mukasa H, Tahara H, Okamoto T. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-?1 regulation of pluripotency. PLoS ONE. 2014;9:e87151 pubmed publisher |
Bershteyn M, Hayashi Y, Desachy G, Hsiao E, Sami S, Tsang K, et al. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature. 2014;507:99-103 pubmed publisher |
Yamamizu K, Piao Y, Sharov A, Zsiros V, Yu H, Nakazawa K, et al. Identification of transcription factors for lineage-specific ESC differentiation. Stem Cell Reports. 2013;1:545-59 pubmed publisher |
Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, et al. Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS ONE. 2012;7:e41572 pubmed publisher |
Jeon K, Lim H, Kim J, Thuan N, Park S, Lim Y, et al. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev. 2012;21:2642-55 pubmed publisher |
Li Z, Yang C, Nakashima K, Rana T. Small RNA-mediated regulation of iPS cell generation. EMBO J. 2011;30:823-34 pubmed publisher |
Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, Sasao M, et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem. 2010;285:29270-8 pubmed publisher |
Takenaka C, Nishishita N, Takada N, Jakt L, Kawamata S. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol. 2010;38:154-62 pubmed publisher |
Rountree C, Ding W, He L, Stiles B. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells. 2009;27:290-9 pubmed publisher |
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72 pubmed |
Miyabayashi T, Teo J, Yamamoto M, McMillan M, Nguyen C, Kahn M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A. 2007;104:5668-73 pubmed |
